Byetta is an injectable prescription drug designed to treat type 2 diabetes in adults by improving blood sugar control. At the time of its launch, the drug was hailed as one of the most innovative new drugs to treat type 2 diabetes in more than a decade.
But, since its initial approval by the U.S. Food and Drug Administration in 2005, Byetta has been linked to potentially deadly side effects, including pancreatitis and cancer. Hundreds of patients injured by Byetta and similar type 2 diabetes drugs have filed lawsuits against drug manufacturer Amylin Pharmaceuticals and other drugmakers over claims that they knew about the risks but failed to warn patients and doctors.
Find out more about how Byetta works, its possible side effects, and the status of the lawsuits.